Get the app!
Back to Trades

Xynos Konstantinos

Chief Medical OfficerCIK 0001956241

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
3
Buy transactions
0
Sell transactions
1
Companies
1
Active
2025–2026

Across 3 filings between 2025–2026, Xynos Konstantinos, Chief Medical Officer, has disclosed $719.2K in transactions — all concentrated in Replimune Group, Inc. (REPL). Their disclosed trades are heavily weighted toward selling$0 in buys and $148.5K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

3 loaded
Aug 12REPL
Replimune Group, Inc.
Xynos KonstantinosChief Medical OfficerSell$148.5K
Apr 7REPL
Replimune Group, Inc.
Xynos KonstantinosChief Medical OfficerGrant$570.8K
Dec 19REPL
Replimune Group, Inc.
Xynos KonstantinosChief Medical OfficerGrant$0

3 filings